Tissue ablation with irreversible electroporation

• US 8,282,631 B2
• Filed: 09/20/2011
• Issued: 10/09/2012
• Est. Priority Date: 12/24/2003
• Status: Active Grant

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Davalos, Rafael, Rubinsky, Boris
• Primary Examiner(s): Peffley, Michael
• Assistant Examiner(s): HUPCZEY, JR, RONALD JAMES
• Application Number:
  US13/237,199
• Publication Number:
  US 20120071874A1
• Time in Patent Office: 385 Days
• Field of Search: 606 32- 50
• US Class Current: 606/32
• CPC Class Codes: A61B 18/12 by passing a current through the tissue to be heated, e.g. high-frequency current
• CPC Class Codes: A61B 18/1233 with circuits for assuring patient safety
• CPC Class Codes: A61B 18/1477 Needle-like probes
• CPC Class Codes: A61B 2018/00577 Ablation
• CPC Class Codes: A61B 2018/00613 Irreversible electroporation reversible electroporation A61N1/327
• CPC Class Codes: A61B 2018/00714 Temperature
• CPC Class Codes: A61B 2018/00761 Duration
• CPC Class Codes: A61B 2018/00827 Current
• CPC Class Codes: A61B 2018/1425 Needle
• CPC Class Codes: A61N 1/0412 Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
• CPC Class Codes: A61N 1/0472 Structure-related aspects
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/327 for enhancing the absorption properties of tissue, e.g. by electroporation

Abstract

A new method for the ablation of undesirable tissue such as cells of a cancerous or non-cancerous tumor is disclosed. It involves the placement of electrodes into or near the vicinity of the undesirable tissue through the application of electrical pulses causing irreversible electroporation of the cells throughout the entire area of the undesirable tissue. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. The amount of tissue ablation achievable through the use of irreversible electroporation without inducing thermal damage is considerable.

Claims

1. A method of ablating tissue cells by non-thermal irreversible electroporation, comprising the steps of:

identifying tissue to be ablated;

placing one or more electrodes near the identified tissue;

applying electrical pulses through the one or more electrodes in an amount which is sufficient to induce irreversible electroporation of cells of the identified tissue, but which is insufficient to induce thermal damage to substantially all of the identified tissue such that the identified tissue cells are killed by irreversible electroporation.

2. The method of claim 1, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to maintain the temperature of the target tissue at 50°

C. or less.

3. The method of claim 1, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to maintain the temperature of the target tissue at 65°

C. or less.

4. The method of claim 1, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to maintain the temperature of the target tissue at 100°

C. or less.

5. The method of claim 1, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to maintain the temperature of at least one of the one or more electrodes below a predetermined temperature.

6. The method of claim 1, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to be insufficient to induce thermal damage based on a bioheat equation.

7. The method of claim 6, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to be insufficient to induce thermal damage based on a modified Penne'"'"'s bioheat equation.

8. The method of claim 6, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to be insufficient to induce thermal damage based on an Arrhenius bioheat equation.

9. The method of claim 6, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to be insufficient to induce thermal damage based on both a modified Penne'"'"'s bioheat equation and an Arrhenius bioheat equation.

10. The method of claim 1, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to be sufficient to induce irreversible electroporation based on a transmembrane potential required for irreversible electroporation of the tissue to be ablated.

11. The method of claim 1, wherein the step of applying includes applying the electrical pulses at a rate of about 1 Hz.

12. The method of claim 1, wherein the step of applying includes applying each electrical pulse having a pulse length of greater than 5 microseconds and less than or equal to 62,000 milliseconds.

13. The method of claim 1, wherein the step of applying includes applying each electrical pulse having a pulse length of between 75 microseconds and 20,000 milliseconds.

14. The method of claim 1, wherein the step of applying includes applying each electrical pulse having a pulse length of 100 microseconds±

10 microseconds.

15. The method of claim 1, wherein the step of applying includes applying each electrical pulse having a pulse length of between 75 microseconds and 20 seconds.

16. The method of claim 1, further comprising detecting that irreversible electroporation of the tissue to be ablated has occurred.

17. The method of claim 16, wherein the step of detecting includes monitoring the electrical impedance of the tissue to be ablated to detect the occurrence of irreversible electroporation.

18. The method of claim 1, further comprising detecting that irreversible electroporation of the tissue to be ablated has occurred based on electrical impedance tomography.

19. The method of claim 1, further comprising:

continuously detecting an electrical resistance of the identified tissue; and

adjusting at least one pulse parameter to achieve irreversible electroporation of the identified tissue based on the detected electrical resistance.

20. The method of claim 1, further comprising:

continuously detecting a current flowing through the one or more electrodes; and

adjusting at least one pulse parameter to achieve irreversible electroporation of the identified tissue based on the detected current flow.

21. A method of ablating tissue cells by non-thermal irreversible electroporation, comprising the steps of:

identifying tissue to be ablated in a living mammal;

placing a plurality of electrodes near the identified tissue; and

applying, through the placed electrodes, electrical pulses to the identified tissue in the living mammal, in an amount which has been predetermined to be sufficient to induce irreversible electroporation of substantially all cells of the identified tissue, but which has been predetermined to be insufficient to induce thermal damage to substantially all cells of the identified tissue such that substantially all of the identified tissue cells are ablated by non-thermal irreversible electroporation, wherein each of the electrical pulses has a pulse duration of at least 5 microseconds.

22. The method of claim 21, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to maintain the temperature of the target tissue at 50°

C. or less.

23. The method of claim 21, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to maintain the temperature of the target tissue at 65°

C. or less.

24. The method of claim 21, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to maintain the temperature of the target tissue at 100°

C. or less.

25. The method of claim 21, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to maintain the temperature of at least one of the one or more electrodes below a predetermined temperature.

26. The method of claim 21, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to be insufficient to induce thermal damage based on a bioheat equation.

27. The method of claim 26, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to be insufficient to induce thermal damage based on a modified Penne'"'"'s bioheat equation.

28. The method of claim 26, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to be insufficient to induce thermal damage based on an Arrhenius bioheat equation.

29. The method of claim 26, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to be insufficient to induce thermal damage based on both a modified Penne'"'"'s bioheat equation and an Arrhenius bioheat equation.

30. The method of claim 21, wherein the step of applying includes applying the electrical pulses in an amount which has been predetermined to be sufficient to induce irreversible electroporation based on a transmembrane potential required for irreversible electroporation of the tissue to be ablated.

31. The method of claim 21, wherein the step of applying includes applying the electrical pulses at a rate of about 1 Hz.

32. The method of claim 21, wherein the step of applying includes applying each electrical pulse having a pulse length of greater than 5 microseconds and less than or equal to 62,000 milliseconds.

33. The method of claim 21, wherein the step of applying includes applying each electrical pulse having a pulse length of between 75 microseconds and 20,000 milliseconds.

34. The method of claim 21, wherein the step of applying includes applying each electrical pulse having a pulse length of 100 microseconds±

10 microseconds.

35. The method of claim 21, wherein the step of applying includes applying each electrical pulse having a pulse length of between 75 microseconds and 20 seconds.

36. The method of claim 21, further comprising detecting that irreversible electroporation of the tissue to be ablated has occurred.

37. The method of claim 36, wherein the step of detecting includes monitoring the electrical impedance of the tissue to be ablated to detect the occurrence of irreversible electroporation.

38. The method of claim 21, further comprising detecting that irreversible electroporation of the tissue to be ablated has occurred based on electrical impedance tomography.

39. The method of claim 21, further comprising:

continuously detecting an electrical resistance of the identified tissue; and

adjusting at least one predetermined pulse parameter to achieve irreversible electroporation of the identified tissue based on the detected electrical resistance.

40. The method of claim 21, further comprising:

continuously detecting a current flowing through the one or more electrodes; and

adjusting at least one predetermined pulse parameter to achieve irreversible electroporation of the identified tissue based on the detected current flow.